Literature DB >> 23016947

Growth requirements and chromosomal instability of induced pluripotent stem cells generated from adult canine fibroblasts.

Sehwon Koh1, Rachael Thomas, Shengdar Tsai, Steve Bischoff, Ji-Hey Lim, Matthew Breen, Natasha J Olby, Jorge A Piedrahita.   

Abstract

In mice and humans, it has been shown that embryonic and adult fibroblasts can be reprogrammed into pluripotency by introducing 4 transcription factors, Oct3/4, Klf4, Sox2, and c-Myc (OKSM). Here, we report the derivation of induced pluripotent stem cells (iPSCs) from adult canine fibroblasts by retroviral OKSM transduction. The isolated canine iPSCs (ciPSCs) were expanded in 3 different culture media [fibroblast growth factor 2 (FGF2), leukemia inhibitory factor (LIF), or FGF2 plus LIF]. Cells cultured in both FGF2 and LIF expressed pluripotency markers [POU5F1 (OCT4), SOX2, NANOG, and LIN28] and embryonic stem cell (ESC)-specific genes (PODXL, DPPA5, FGF5, REX1, and LAMP1) and showed strong levels of alkaline phosphatase expression. In vitro differentiation by formation of embryoid bodies and by directed differentiation generated cell derivatives of all 3 germ layers as confirmed by mRNA and protein expression. In vivo, the ciPSCs created solid tumors, which failed to reach epithelial structure formation, but expressed markers for all 3 germ layers. Array comparative genomic hybridization and chromosomal fluorescence in situ hybridization analyses revealed that while retroviral transduction per se did not result in significant DNA copy number imbalance, there was evidence for the emergence of low-level aneuploidy during prolonged culture or tumor formation. In summary, we were able to derive ciPSCs from adult fibroblasts by using 4 transcription factors. The isolated iPSCs have similar characteristics to ESCs from other species, but the exact cellular mechanisms behind their unique co-dependency on both FGF2 and LIF are still unknown.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23016947      PMCID: PMC3585736          DOI: 10.1089/scd.2012.0393

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  46 in total

1.  Canine embryo-derived stem cells--toward clinically relevant animal models for evaluating efficacy and safety of cell therapies.

Authors:  Marlon R Schneider; Heiko Adler; Joachim Braun; Beate Kienzle; Eckhard Wolf; Hans-Jochem Kolb
Journal:  Stem Cells       Date:  2007-07       Impact factor: 6.277

2.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

3.  Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential.

Authors:  Andrea K Vaags; Suzana Rosic-Kablar; Cathy J Gartley; Yan Zhen Zheng; Alden Chesney; Daniel A F Villagómez; Stephen A Kruth; Margaret R Hough
Journal:  Stem Cells       Date:  2009-02       Impact factor: 6.277

4.  Defined, feeder-independent medium for human embryonic stem cell culture.

Authors:  Tenneille Ludwig; James A Thomson
Journal:  Curr Protoc Stem Cell Biol       Date:  2007-09

5.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

6.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

7.  Derivation, characterization, and in vitro differentiation of canine embryonic stem cells.

Authors:  Brian Hayes; Sara R Fagerlie; Aravind Ramakrishnan; Szczepan Baran; Michael Harkey; Lynn Graf; Merav Bar; Ausra Bendoraite; Muneesh Tewari; Beverly Torok-Storb
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

8.  Characterization of canine embryonic stem cell lines derived from different niche microenvironments.

Authors:  Jared T Wilcox; Esther Semple; Cathy Gartley; Brigitte A Brisson; Steven D Perrault; Daniel A F Villagómez; Chandrakant Tayade; Sandy Becker; Robert Lanza; Dean H Betts
Journal:  Stem Cells Dev       Date:  2009-10       Impact factor: 3.272

9.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

10.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

View more
  13 in total

Review 1.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 2.  Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Taruna Anand; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Genetic Basis of Dilated Cardiomyopathy in Dogs and Its Potential as a Bidirectional Model.

Authors:  Karen R Gaar-Humphreys; Talitha C F Spanjersberg; Giorgia Santarelli; Guy C M Grinwis; Viktor Szatmári; Bernard A J Roelen; Aryan Vink; J Peter van Tintelen; Folkert W Asselbergs; Hille Fieten; Magdalena Harakalova; Frank G van Steenbeek
Journal:  Animals (Basel)       Date:  2022-06-29       Impact factor: 3.231

Review 4.  From "ES-like" cells to induced pluripotent stem cells: a historical perspective in domestic animals.

Authors:  Sehwon Koh; Jorge A Piedrahita
Journal:  Theriogenology       Date:  2014-01-01       Impact factor: 2.740

5.  A novel canine kidney cell line model for the evaluation of neoplastic development: karyotype evolution associated with spontaneous immortalization and tumorigenicity.

Authors:  R Omeir; R Thomas; B Teferedegne; C Williams; G Foseh; J Macauley; L Brinster; J Beren; K Peden; M Breen; A M Lewis
Journal:  Chromosome Res       Date:  2015-05-10       Impact factor: 5.239

6.  Comparison of American mink embryonic stem and induced pluripotent stem cell transcriptomes.

Authors:  Aleksei G Menzorov; Natalia M Matveeva; Marios N Markakis; Venyamin S Fishman; Knud Christensen; Anna A Khabarova; Inna E Pristyazhnyuk; Elena A Kizilova; Susanna Cirera; Razvan Anistoroaei; Oleg L Serov
Journal:  BMC Genomics       Date:  2015-12-16       Impact factor: 3.969

7.  Oocytes, embryos and pluripotent stem cells from a biomedical perspective.

Authors:  Poul Hyttel; Laís Vicari de Figueiredo Pessôa; Jan Bojsen-Møller Secher; Katarina Stoklund Dittlau; Kristine Freude; Vanessa J Hall; Trudee Fair; Remmy John Assey; Jozef Laurincik; Henrik Callesen; Torben Greve; Lotte Björg Stroebech
Journal:  Anim Reprod       Date:  2019-10-23       Impact factor: 1.807

Review 8.  Perspectives of pluripotent stem cells in livestock.

Authors:  Dharmendra Kumar; Thirumala R Talluri; Naresh L Selokar; Iqbal Hyder; Wilfried A Kues
Journal:  World J Stem Cells       Date:  2021-01-26       Impact factor: 5.326

Review 9.  Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives.

Authors:  Helena D Zomer; Atanásio S Vidane; Natalia N Gonçalves; Carlos E Ambrósio
Journal:  Stem Cells Cloning       Date:  2015-09-28

Review 10.  Canine Pluripotent Stem Cells: Are They Ready for Clinical Applications?

Authors:  Dean H Betts; Ian C Tobias
Journal:  Front Vet Sci       Date:  2015-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.